CA-S27: A novel Lewis a associated carbohydrate epitope is diagnostic and prognostic for cholangiocarcinoma

Cancer Science

Volumn 104, Issue 10, 2013, Pages 1278-1284

  Silsirivanit, Atit ^a,b   Araki, Norie ^b   Wongkham, Chaisiri ^a   Vaeteewoottacharn, Kulthida ^a   Pairojkul, Chawalit ^a   Kuwahara, Kazuhiko ^b   Narimatsu, Yoshiki ^c   Sawaki, Hiromichi ^c   Narimatsu, Hisashi ^c   Okada, Seiji ^d   Sakaguchi, Nobuo ^b   Wongkham, Sopit ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

^b KUMAMOTO UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^d KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE ANTIGEN; CARBOHYDRATE ANTIGEN S27; EPITOPE; FUCOSYLTRANSFERASE; MONOCLONAL ANTIBODY; MUCIN 5AC; SMALL INTERFERING RNA; SOYBEAN AGGLUTININ; TISSUE EXTRACT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BILE DUCT CARCINOMA; CANCER DIAGNOSIS; CANCER INHIBITION; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATOBILIARY DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE; TUMOR GROWTH;

AGED; AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL ADHESION; CHOLANGIOCARCINOMA; DIAGNOSIS, DIFFERENTIAL; DIGESTIVE SYSTEM NEOPLASMS; EPITHELIAL CELLS; EPITOPES; FEMALE; FUCOSYLTRANSFERASES; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUCIN 5AC; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; OLIGOSACCHARIDES; PREDICTIVE VALUE OF TESTS; RNA INTERFERENCE; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED;

EID: 84884979119     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12222     Document Type: Article

References (23)

1. Hakomori S. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res 1989; 52: 257-331.
2. Silsirivanit A, Araki N, Wongkham C et al. A novel serum carbohydrate marker on mucin 5AC: values for diagnostic and prognostic indicators for cholangiocarcinoma. Cancer 2011; 117: 3393-403.
3. IARC. Opisthorchis viverrini and Clonorchis sinensis. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans A Review of Human Carcinogens. 100. Lyon, France: International Agency for Research on Cancer; 2011; 347-76.
4. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 2001; 33: 1353-7.
5. Shaib YH, Davila JA, McGlynn K, El-Serag HB. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol 2004; 40: 472-7.
6. Morise Z, Sugioka A, Tokoro T et al. Surgery and chemotherapy for intrahepatic cholangiocarcinoma. World J Hepatol 2010; 2: 58-64.
7. Guglielmi A, Ruzzenente A, Campagnaro T et al. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg 2009; 33: 1247-54.
8. Sripa B, Leungwattanawanit S, Nitta T et al. Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100). World J Gastroenterol 2005; 11: 3392-7.
9. Obchoei S, Weakley SM, Wongkham S et al. Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma. Mol Cancer 2011; 10: 102.
10. Maruyama M, Kobayashi N, Westerman KA et al. Establishment of a highly differentiated immortalized human cholangiocyte cell line with SV40T and hTERT. Transplantation 2004; 77: 446-51.
11. Tateno H, Mori A, Uchiyama N et al. Glycoconjugate microarray based on an evanescent-field fluorescence-assisted detection principle for investigation of glycan-binding proteins. Glycobiology 2008; 18: 789-98.
12. Boonla C, Sripa B, Thuwajit P et al. MUC1 and MUC5AC mucin expression in liver fluke-associated intrahepatic cholangiocarcinoma. World J Gastroenterol 2005; 11: 4939-46.
13. Bamrungphon W, Prempracha N, Bunchu N et al. A new mucin antibody/enzyme-linked lectin-sandwich assay of serum MUC5AC mucin for the diagnosis of cholangiocarcinoma. Cancer Lett 2007; 247: 301-8.
14. Ito H, Kuno A, Sawaki H et al. Strategy for glycoproteomics: identification of glyco-alteration using multiple glycan profiling tools. J Proteome Res 2009; 8: 1358-67.
15. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
16. Kimura H, Kudo T, Nishihara S et al. Murine monoclonal antibody recognizing human alpha(1, 3/1, 4)fucosyltransferase. Glycoconj J 1995; 12: 802-12.
17. Boonla C, Wongkham S, Sheehan JK et al. Prognostic value of serum MUC5AC mucin in patients with cholangiocarcinoma. Cancer 2003; 98: 1438-43.
18. Luengpailin S, Wongkham S, Wongkham C et al. Demonstration of a biliary-associated glycoprotein in human serum. Clin Chim Acta 1996; 244: 237-40.
19. Dogan UB, Gumurdulu Y, Golge N, Kara B. Relationship of CA 19-9 with choledocholithiasis and cholangitis. Turk J Gastroenterol 2011; 22: 171-7.
20. Sinakos E, Saenger AK, Keach J, Kim WR, Lindor KD. Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma. Clin Gastroenterol Hepatol 2011; 9: 434-9.
21. Yamazoe S, Tanaka H, Sawada T et al. RNA interference suppression of mucin 5AC (MUC5AC) reduces the adhesive and invasive capacity of human pancreatic cancer cells. J Exp Clin Cancer Res 2010; 29: 53.
22. Aubert M, Panicot-Dubois L, Crotte C et al. Peritoneal colonization by human pancreatic cancer cells is inhibited by antisense FUT3 sequence. Int J Cancer 2000; 88: 558-65.
23. Yin X, Rana K, Ponmudi V, King MR. Knockdown of fucosyltransferase III disrupts the adhesion of circulating cancer cells to E-selectin without affecting hematopoietic cell adhesion. Carbohydr Res 2010; 345: 2334-42.